Public consultation on including underrepresented populations in clinical trials

Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.
WHO invites stakeholders to contribute to a public consultation on improving the inclusion of underrepresented populations in clinical trials. The consultation seeks views on current challenges, barriers to participation, priorities for improving inclusion, and actions that could strengthen trial design, recruitment, reporting, accountability and community engagement.
WHO welcomes input from researchers, clinical trialists, ethics committee members, funders, policymakers, healthcare professionals, organisations representing patients and communities, and other interested stakeholders across different countries and regions.
There are 22 questions in this survey.
 
Close